| Mrs Marcia Starr-helfand, RPT | |
|
520 West Ave, Norwalk, CT 06850-4034 | |
| (203) 852-2417 | |
| (203) 852-2310 |
| Full Name | Mrs Marcia Starr-helfand |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist - Orthopedic |
| Location | 520 West Ave, Norwalk, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114047826 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 003536 (Connecticut) | Secondary |
| 2251X0800X | Physical Therapist - Orthopedic | 003536 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Marcia Starr-helfand, RPT 4 Eric Ct, Norwalk, CT 06851-5507 Ph: (203) 838-0261 | Mrs Marcia Starr-helfand, RPT 520 West Ave, Norwalk, CT 06850-4034 Ph: (203) 852-2417 |
News Archive
The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete testing in the trial. Adding the chemotherapy carboplatin and the molecularly targeted drug veliparib to standard presurgery chemotherapy improved outcomes for women with triple-negative breast cancer, according to results from the I-SPY 2 trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that the U.S. Food and Drug Administration has provided guidance on the clinical program required to assess the approvability of Restanza™ (cethromycin), a novel oral once-a-day antibiotic, in the treatment of outpatient community acquired bacterial pneumonia (CABP) as well as biodefense indications including anthrax, plague and tularemia.
Senators voted Thursday to give $26 billion in aid to states and schools, $16 billion of which will be directed to Medicaid programs around the nation as the House prepares to return during its recess to cast votes on the legislation.
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop a pharmacodynamic assay to monitor the Akt/mTOR signaling pathway.
› Verified 1 days ago
Dana Fulton, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 698 West Ave, Norwalk, CT 06850 Phone: 203-852-3400 | |
Ms. Wendy Lee Boller, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 520 West Ave, Norwalk, CT 06850 Phone: 203-852-3400 | |
Christine Flanigan, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 520 West Ave, Norwalk, CT 06850 Phone: 203-852-3400 | |
Courtney Lyddy, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 40 Cross St, Rehabilitation Services Of Norwalk Hospital, Norwalk, CT 06851 Phone: 203-840-3170 | |
Ms. Chocolate Gonzalez Ocampo, RPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 34 Midrocks Dr, Norwalk, CT 06851 Phone: 203-847-9686 | |
Mrs. Laura Eves Yarish, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 698 West Ave, Norwalk, CT 06850 Phone: 203-852-3400 Fax: 203-852-3418 | |
Professional Occupational & Physical Therapy, Pllc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 346 Main Ave, Norwalk, CT 06851 Phone: 203-847-4400 Fax: 203-847-4442 |